Picture of Human Metabolome Technologies logo

6090 Human Metabolome Technologies Income Statement

0.000.00%
jp flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Annual income statement for Human Metabolome Technologies, fiscal year end - June 30th, JPY millions except per share, conversion factor applied.

2019
June 30th
2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
Period Length:15 M12 M12 M12 M12 M
Source:YuhoYuhoYuhoYuhoYuho
Standards:
JAS
JAS
JAS
JAS
JAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue9891,1181,1241,2231,299
Cost of Revenue
Gross Profit673857806840860
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses1,5921,1441,0941,0231,084
Operating Profit-602-25.130200215
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-591-24.550.9262237
Provision for Income Taxes
Net Income After Taxes-596-47.858.2268286
Net Income Before Extraordinary Items
Net Income-596-47.858.2268286
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-596-47.858.2268286
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-93.5-7.2610.844.447.9
Dividends per Share